Table 1 Participant characteristics
From: Association of reduced inner retinal thicknesses with chronic kidney disease
Variable | Population value |
|---|---|
Age, years, mean (SD) | 65.3 (9.5) |
Female, n (%) | 106 (44) |
eGFR, ml/min/1.73m2, mean (SD) | 67 (25) |
Weight, Kg, mean (SD) | 89.0 (20.1) |
BMI, kg/m2, mean (SD) | 31.0 (6.4) |
Hypertension, n (%) | 157 (65) |
SBP, mmHg, mean (SD) | 136 (22) |
DBP, mmHg, mean (SD) | 81 (13) |
MABP (1/3 SBP + 2/3 DBP), mmHg, mean (SD) | 99 (13) |
HbA1c mean, mmol/mol, (SD) | 53 (18) |
Total Cholesterol, mean, mmol/L (SD) | 3.92 (1.18) |
HDL, mean, mmol/L (SD) | 1.33 (0.45) |
LDL, mean, mmol/L (SD) | 2.28 (0.97) |
Troponin, mean, mmol/L (SD) | 17.8 (28.9) |
CRP, mean, mmol/L (SD) | 9.5 (35.6) |
Pack Years, mean (SD) | 39.8 (35.0) |
CVD, n (%) | 100 (41.5) |
Diabetes mellitus, n (%) | 93 (39) |
 Type 1, n (%) | 13 (5) |
 Type 2, n (%) | 80 (33) |
Insulin, n (%) | 29 (31) |
Previous CVA, n (%) | 19 (8) |
Antihypertensives, n (%) | 83 (35) |
Hypoglycaemics, n (%) | 68 (29) |
Statins, n (%) | 164 (69) |
Diuretics, n (%) | 63 (27) |
NSAIDs, n (%) | 12 (5) |
Vitamin supplements, n (%) | 48 (20) |
Rheumatoid arthritis, n (%) | 10 (9) |
Hypertension treatment, n (%) | |
 None | 78 (33) |
 < 5 years | 54 (23) |
 5–10 years | 38 (16) |
 > 10 years | 64 (27) |
Smoking, n (%) | |
 Never | 119 (49) |
 Ex | 87 (36) |
 Current | 35 (15) |
Alcohol, n (%) | |
 none | 134 (56) |
 1–5 units | 38 (16) |
 6–10 units | 28 (12) |
 15–20 units | 25 (10) |
 > 25 units | 12 (5) |
QRISK2 score, n (%) | |
 1 | 38 (34) |
 2 | 35 (31) |
 3 | 38 (34) |